Precigen (PGEN) Times Interest Earned (2012 - 2026)
Precigen (PGEN) reported Times Interest Earned of -$2.06 for Q1 2026, up 99.99% year-over-year from -$1.03 in Q1 2025, and up 71.8% quarter-over-quarter from -$7.31 in Q4 2025.
Precigen (PGEN) Times Interest Earned (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Times Interest Earned data on file, last reported at -$2.06 in Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$2.06, up 99.99% year-over-year; the trailing twelve-month figure through Mar 2026 was -$13.86 (up 99.95% YoY), and the FY2025 annual result was -$28.58, up 99.87% from the prior year.
- Times Interest Earned rose to -$2.06 in Q1 2026 per PGEN's latest filing, from -$7.31 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$2.06 in Q1 2026 and troughed at -$30420.5 in Q2 2024.
- A 5-year average of -$6801.0 and a median of -$72.46 in 2023 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2023 and 2026: Times Interest Earned plunged 559759.89% in 2023, then soared 99.99% in 2026.
- A 5-year view of Times Interest Earned shows it stood at -$34.22 in 2022, then sank by 14188.13% to -$4889.1 in 2023, then plunged by 117.44% to -$10631.0 in 2024, then surged by 99.93% to -$7.31 in 2025, then jumped by 71.8% to -$2.06 in 2026.
- Business Quant data shows PGEN's Times Interest Earned at -$2.06 in Q1 2026, -$7.31 in Q4 2025, and -$38.23 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | -2.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.06 |
| Dec 31, 2025 | -7.31 |
| Sep 30, 2025 | -38.23 |
| Mar 31, 2025 | -22,596.00 |
| Sep 30, 2024 | -10,631.00 |
| Jun 30, 2024 | -30,420.50 |
| Mar 31, 2024 | -12,205.00 |
| Dec 31, 2023 | -4,889.14 |
| Sep 30, 2023 | -20,937.00 |
| Jun 30, 2023 | -155.29 |
| Mar 31, 2023 | -72.46 |
| Dec 31, 2022 | -34.22 |
| Sep 30, 2022 | -3.74 |
| Jun 30, 2022 | -11.71 |
| Mar 31, 2022 | -10.87 |
| Dec 31, 2021 | -4.51 |
| Sep 30, 2021 | -4.52 |
| Jun 30, 2021 | -5.66 |
| Mar 31, 2021 | -3.90 |
| Dec 31, 2020 | -2.00 |